DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Research Programs
  3. Ovarian Cancer
  4. Research Highlights/News
  5. 2016 Ovarian Cancer Research Program

Ovarian Cancer

NEWS RELEASE

Released: January 11, 2016

Defense Health Program
Department of Defense Ovarian Cancer Research Program
Funding Opportunities for Fiscal Year 2016 (FY16)

The FY16 Defense Appropriations Act provides $20 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support high-impact ovarian cancer research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

The OCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY16 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in February 2016. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism PI Eligibility Key Mechanism Elements Funding
Clinical Development Award Must be an independent investigator at or above the level of Assistant Professor (or equivalent)
  • Supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life
  • Near-term impact is expected
  • Clinical trials are not allowed
  • Preliminary data are required
  • Pre-application is required; application is by invitation only
  • Maximum funding of $450,000 in direct costs (plus indirect costs)
  • Period of performance should not exceed 2 years
Investigator-Initiated Research Award Must be an independent investigator at or above the level of Assistant Professor (or equivalent)
  • Supports meritorious basic and clinically oriented research in ovarian cancer
  • Impact is an important review criterion
  • Preliminary data are required
  • Clinical trials are not allowed
  • Pre-application is required; application is by invitation only
  • Maximum funding of $450,000 in direct costs (plus indirect costs)
  • Period of performance should not exceed 3 years
Ovarian Cancer Academy Award - Early-Career Investigator Early-Career Investigator must be within the first 3 years of his/her first faculty position (or equivalent) at the time of submission. The first faculty position (or equivalent) may be either tenure-track or non-tenure track.
  • Supports the addition of new Early-Career Investigators to the unique, interactive virtual academy that will provide intensive mentoring, national networking, and a peer group for junior faculty
  • Early-Career Investigators from less ovarian cancer research-resourced organizations are encouraged to apply
  • Designated mentor who is an experienced ovarian cancer researcher with ovarian cancer funding is required
  • Preliminary data are required
  • Pre-application is required; application is by invitation only
  • Maximum funding of $725,000 in direct costs (plus indirect costs)
  • Period of performance of 5 years
Pilot Award Investigators at or above the postdoctoral level (or equivalent)
  • Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward
  • Innovation and Impact are important review criteria
  • Goal is to develop preliminary data; thus, preliminary data are not required, but allowed
  • Clinical trials are not allowed
  • Pre-application is required and is blinded; application submission is by invitation only
  • Maximum funding of $250,000 in direct costs (plus indirect costs)
  • Period of performance should not exceed 2 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to help@eBRAP.org. For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (https://CDMRP.HEALTH.MIL).

Point of Contact:

CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil


Last updated Tuesday, November 12, 2024